Results
Each responding pharmacy (7 of 10) varied in the number of HIV/AIDS patients served and prescription volume. All pharmacists had completed HIV/AIDS-related con- tinuing education programmes, and some had other advanced training. The type of MTMS being offered varied at each pharmacy with ‘individualized counselling by a pharmacist when overuse or underuse was detected’ and ‘refill reminders by telephone’ being actively used by the largest proportion of patients. Most, but not all, pharmacists cited reimburse- ment as a barrier to MTMS provision. Pharmacists believed the MTMS they provide resulted in improved satisfaction (patient and provider), medication usage, therapeutics response and patient quality of life.